S1192 Physician Density and Hospitalization for Inflammatory Bowel Disease: How Much Does Access Matter?

Abstract

G A A b st ra ct s disease rather than cancer/dysplasia (88% vs 29%; p=0.02). In contrast, surgical indication did not influence chronic pouch inflammation among -PSC (26% vs 18%, p=0.38).Conclusions: +PSC have unique clinical and serologic characteristics that distinguish them from -PSC. +PSC patients who undergo IPAA for refractory disease rather than dysplasia are more likely to develop chronic pouch inflammation. Validation of these findings in a larger cohort is warranted.